Table 4.
HR | [95% CI] | p-value | |||
---|---|---|---|---|---|
| |||||
Model | Parameter | Level | |||
GE Junction | LVI | No | REF | ||
Baseline Pathologic Model | Yes | 2.78 | [1.57 – 4.93] | 0.0005 | |
N Stage | N0 | REF | |||
N1+ | 2.71 | [1.49 – 4.92] | 0.0010 | ||
| |||||
Gastric | T Stage | T0–T1b | REF | ||
Baseline Pathologic Model | T2 | 0.40 | [0.04 – 4.51] | 0.0217 | |
T3–T4 | 3.87 | [0.89 – 16.89] | |||
N Stage | N0 | REF | |||
N1+ | 7.09 | [2.08 – 24.22] | 0.0018 | ||
| |||||
GE Junction | SUVmax Response | 1.00 | [1.00 – 1.01] | 0.20 | |
Pathologic Model + SUVmax Response | LVI | No | REF | ||
Yes | 2.97 | [1.66 – 5.30] | 0.0002 | ||
N Stage | N0 | REF | |||
N1+ | 2.27 | [1.50 – 4.92] | 0.0010 | ||
| |||||
Gastric | SUVmax Response | 1.00 | [0.99 – 1.01] | 0.66 | |
Pathologic Model + SUVmax Response | T Stage | T0–T1b | REF | ||
T2 | 0.40 | [0.04 – 4.51] | 0.0253 | ||
T3–T4 | 3.87 | [0.89 – 16.89] | |||
N Stage | N0 | REF | |||
N1+ | 7.05 | [2.06 – 24.10] | 0.0019 |